Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759219 | PMC |
| http://dx.doi.org/10.5152/tjg.2020.19820 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vulvar dermatofibrosarcoma protuberans masquerading as angiomyxoma: A case report and review of 85 cases.
Indian J Pathol Microbiol
March 2025
Department of Obstetrics and Gynecology, Topiwala National Medical College and BYL Nair Charitable Hospital, Mumbai, Maharashtra, India.
Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous mesenchymal locally aggressive sarcoma with high recurrence. We report a case of recurrent vulvar DFSP, and a literature review was performed with a PubMed search using the terms "Dermatofibrosarcoma protuberans" and "vulva." Total 85 cases with vulvar DFSP were analyzed for their clinicopathological features among fibrosarcomatous DFSP (FS-DFSP) and non-FS-DFSP.
View Article and Find Full Text PDFImportance: Inequitable access to transplant in the US is well recognized, yet the nature and extent of upstream disparities in care prior to transplant are unknown.
Objective: To understand patterns of referral for lung transplant by race, ethnicity, and neighborhood-level socioeconomic status.
Design, Setting, And Participants: This retrospective cohort study included adults aged 18 to 80 years with obstructive and restrictive lung disease from a single large-volume transplant center in Cleveland, Ohio, who were diagnosed between January 1, 2006, and May 11, 2023.
This case report describes a minimal intervention dentistry approach for a tense-cooperative boy with an enamel hypoplastic defect in an incisor as a result of a traumatic dental injury to its predecessor. The primary mandibular left central incisor (tooth O) was avulsed when the child was 2.7 years of age.
View Article and Find Full Text PDFThis article presents the clinical case of a 42-year-old woman with chronic pain in her left temporomandibular joint (TMJ) and limited mouth opening. The patient also reported anxiety and difficulty sleeping. Cone beam computed tomography revealed impacted maxillary third molars and hypertrophy of the nasal turbinates.
View Article and Find Full Text PDFDoravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trial.
Clin Infect Dis
March 2025
Merck & Co., Inc., Rahway, NJ, USA.
Background: Doravirine/islatravir is an investigational, once-daily regimen being studied for HIV-1 treatment.
Methods: In this phase 3, double-blind, non-inferiority trial, previously untreated people with HIV-1 (≥18 years) were randomized (1:1) and stratified by HIV-1 RNA (≤/>100,000 copies/mL) and CD4 count ( View Article and Find Full Text PDF
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!